Cell and gene therapy manufacturers are partnering with specialist technology companies to address the challenges associated with scaling complex therapies. Rece...

Round led by Molten Ventures alongside existing investors Hargreave Hale AIM VCT, XTX Ventures, Guinness Ventures, Meltwind and Ascension Investment will sup...

 ProBioGen today announced a new collaboration with VarmX B.V. for the development of their second therapeutic Factor X candidate. The partnership will advance V...

Celonic AG, a Swiss-based biologics Contract Development and Manufacturing Organisation (CDMO), and Leukocare AG, a leading provider of drug product development ...

Cognizant today announced it has been selected by Novartis for a five-year, AI-enabled integrated IT operations engagement, expanding a strategic relationship th...

New research on AI-driven biologics discovery identifies Carterra's high-throughput SPR platforms as central to the Lab-in-the-Loop (LitL) workflow reshaping dru...

Offers UK academic, biotech and biopharma researchers direct access to specialist project support, 10x Genomics Chromium Single Cell-based workflows, sequencing ...

Study to evaluate mproUK-based sequential fibrinolysis in approximately 290 STEMI patients across 17 clinical sites in Türkiye Thrombolytic Science, LLC (...

Lessons learned from scaling a diagnostic platform from early prototype to more than 10x production growth ·       IVD inno...

Milestone marks the transition of Low Dose IL-2 from clinical development to a scalable, regulatory-ready commercial manufacturing processStrategic step strength...